cetyl alcohol
Approved
Aug 2, 1990
Cetyl alcohol, also known as hexadecan-1-ol and palmityl alcohol, is a C-16 fatty alcohol with the formula CH3(CH2)15OH. At room temperature, cetyl alcohol takes the form of a waxy white solid or flakes. The name cetyl refers to whale oil (cetacea oil, from Latin: cetus, lit. 'whale', from Ancient Greek: κῆτος, romanized: kētos, lit. 'huge fish') from which it was first isolated. — Wikipedia
Clinical trial activity
4 trials · 5 clinical orgs · 1 marketing orgs
Earliest trial started Feb 13, 2020 (NCT04606134)
Timeline
1980s
- Oct 20, 1989
Orphan Drug Designation
1990s
- Aug 2, 1990
GlaxoSmithKline — Earliest FDA Approval
- Aug 2, 1990
GlaxoSmithKline — NDA Secondary Org
- Aug 2, 1990
GlaxoSmithKline — NDA Organization
2020s
- Jan 1, 2025
Earliest Phase 3 Sponsor(trial)
Indications
Approved for
Mechanism of action
- UnclearUnclear
Unclear unclear
Combination products
exosurf neonatal
Approval history
- approvedPriority reviewAug 2, 1990
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Sources
- WikipediaCetyl alcohol ↗
- WikipediaCetaphil ↗
Also known as
- 4-nitro-4'-aminodiphenyl sulfone
- benzenamine, 4-((4-nitrophenyl)sulfonyl)-
- cetaphil
- cetaphil
- cetaphil
- cetaphil skin cleansing lotion
- cetyl alcohol, propylene glycol, sodium lauryl sulfate non-lipid cleansing lotion
- nuvo
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT07066280 | Phase 3 | Apr 10, 2025 | Sun Yat-Sen University |
| NCT06357221 | Phase 4 | Apr 8, 2024 | Dermatology Consulting Services, High Point NC, Galderma |
| NCT04341623 | N/A | Jun 30, 2020 | Galderma, Wake Forest University |
| NCT04606134 | N/A | Feb 13, 2020 | University of Rochester |
Organizations
Research & Development (5)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Galderma | For profit | 2 | 1 | 2 | 2020 |
| Dermatology Consulting Services, High Point NC | Academic/Hospital | 1 | 0 | 1 | 2024 |
| Sun Yat-Sen University | Academic/Hospital | 1 | 1 | 1 | 2025 |
| University of Rochester | Academic/Hospital | 1 | 1 | 1 | 2020 |
| Wake Forest University | Academic/Hospital | 1 | 1 | 1 | 2020 |
Marketing (2)
| Organization | Org type | Relationship | Date |
|---|---|---|---|
| GlaxoSmithKline | For profit | NDA2 | Aug 2, 1990 |
| GlaxoSmithKline | For profit | NDA | Aug 2, 1990 |